Key result
Concomitant preexisting CeVD and CVD was associated with higher LDL-C <1.8 mmol/L attainment, though overall attainment across all stroke/TIA admissions was only 14.9%.
Why the study?
Lowering LDL-C is crucial for secondary stroke prevention in stroke patients with preexisting CVD or CeVD, but data on attainment of guideline-recommended LDL-C levels are lacking.
What proportion of patients admitted with acute ischemic stroke or transient ischemic attack in China achieve guideline-recommended LDL-C targets at admission, and how does attainment vary by preexisting cerebrovascular and cardiovascular disease history?
Cross-Sectional (n=858,509)
Yes
What proportion of patients admitted with acute ischemic stroke or transient ischemic attack in China achieve guideline-recommended LDL-C targets at admission, and how does attainment vary by preexisting cerebrovascular and cardiovascular disease history?
Real-world attainment of guideline-recommended LDL-C targets prior to acute ischemic stroke or TIA admission in China is substantially suboptimal, highlighting an urgent need for improved dyslipidemia management in secondary prevention.
Answers are grounded in this paper and cite their sources.
Low LDL-C attainment in Chinese stroke/TIA admissions signals secondary prevention gaps; leaves open whether preexisting CeVD/CVD refines risk stratification.
BACKGROUND: Lowering low-density lipoprotein cholesterol (LDL-C) is crucial for secondary stroke prevention in stroke patients with preexisting cardiovascular diseases (CVD) or cerebrovascular diseases (CeVD). However, data on attainment of guideline-recommended LDL-C levels are lacking. METHODS: We analyzed data from the Chinese Stroke Center Alliance (CSCA) program for patients with ischemic stroke and transient ischemic attack (TIA) hospitalized between August 2015 and July 2019. Participants were classified into different disease groups according to preexisting CeVD (stroke/TIA) or CVD [coronary heart disease (CHD) or myocardial infarction (MI)]. RESULTS: Of 858,509 patients presenting with an acute stroke/TIA, 251,176 (29.3%) had a preexisting CeVD, 44,158 (5.1%) had preexisting CVD, 33,070 (3.9%) had concomitant preexisting CeVD and CVD, and 530,105 (61.7%) had no documented history of CeVD/CVD. Overall, only 397,596 (46.3%) met the target for LDL-C <2.6 mmol/L, 128,177 (14.9%) for LDL-C <1.8 mmol/L and 55,275 (6.4%) for LDL-C <1.4 mmol/L, and patients with concomitant CeVD and CVD had higher attainment rates than other disease groups (P<0.001). Despite improvements over time in the proportion of patients who attain LDL-C targets (P for trend <0.05), it remains suboptimal. Younger age, women, having a history of hypertension or dyslipidemia, current smoking or drinking, and being admitted to hospitals located in eastern China were associated with lower odds of meeting the LDL-C goals. CONCLUSIONS: Overall attainment of guideline LDL-C targets in a population of stroke/TIA patients is low and indicates the need for better management of dyslipidemia, particularly for high-risk stroke patients with pre-existing CeVD or CVD.
No takes yet. Share an insight, caveat, or question.
Gu et al. (2021) conducted a cross-sectional in Acute ischemic stroke or transient ischemic attack (TIA) (n=858,509). Concomitant preexisting cerebrovascular disease (CeVD) and cardiovascular disease (CVD) vs. No documented history of CeVD or CVD was evaluated on Attainment of guideline-recommended LDL-C target <1.8 mmol/L at hospital admission (OR 1.36, 95% CI 1.29-1.43, p=<0.001). Concomitant preexisting CeVD and CVD was associated with higher LDL-C <1.8 mmol/L attainment, though overall attainment across all stroke/TIA admissions was only 14.9%.
Synapse has enriched 10 related papers. Consider them for comparative context: